S&P 500   3,839.71 (-0.35%)
DOW   30,992.92 (-0.59%)
QQQ   325.24 (-0.34%)
AAPL   135.28 (-1.16%)
MSFT   227.32 (+1.04%)
FB   273.05 (+0.07%)
GOOGL   1,879.03 (-0.27%)
AMZN   3,285.75 (-0.64%)
TSLA   839.70 (-0.63%)
NVDA   547.12 (-1.37%)
BABA   257.09 (-1.12%)
CGC   33.32 (-0.72%)
GE   11.08 (+0.09%)
MU   84.58 (-0.51%)
AMD   95.40 (+4.23%)
NIO   58.68 (+0.58%)
T   28.65 (-0.62%)
F   11.59 (+0.52%)
ACB   10.29 (-7.88%)
BA   206.00 (-0.68%)
DIS   174.12 (+1.66%)
NFLX   581.69 (+0.32%)
GILD   66.45 (-0.79%)
S&P 500   3,839.71 (-0.35%)
DOW   30,992.92 (-0.59%)
QQQ   325.24 (-0.34%)
AAPL   135.28 (-1.16%)
MSFT   227.32 (+1.04%)
FB   273.05 (+0.07%)
GOOGL   1,879.03 (-0.27%)
AMZN   3,285.75 (-0.64%)
TSLA   839.70 (-0.63%)
NVDA   547.12 (-1.37%)
BABA   257.09 (-1.12%)
CGC   33.32 (-0.72%)
GE   11.08 (+0.09%)
MU   84.58 (-0.51%)
AMD   95.40 (+4.23%)
NIO   58.68 (+0.58%)
T   28.65 (-0.62%)
F   11.59 (+0.52%)
ACB   10.29 (-7.88%)
BA   206.00 (-0.68%)
DIS   174.12 (+1.66%)
NFLX   581.69 (+0.32%)
GILD   66.45 (-0.79%)
S&P 500   3,839.71 (-0.35%)
DOW   30,992.92 (-0.59%)
QQQ   325.24 (-0.34%)
AAPL   135.28 (-1.16%)
MSFT   227.32 (+1.04%)
FB   273.05 (+0.07%)
GOOGL   1,879.03 (-0.27%)
AMZN   3,285.75 (-0.64%)
TSLA   839.70 (-0.63%)
NVDA   547.12 (-1.37%)
BABA   257.09 (-1.12%)
CGC   33.32 (-0.72%)
GE   11.08 (+0.09%)
MU   84.58 (-0.51%)
AMD   95.40 (+4.23%)
NIO   58.68 (+0.58%)
T   28.65 (-0.62%)
F   11.59 (+0.52%)
ACB   10.29 (-7.88%)
BA   206.00 (-0.68%)
DIS   174.12 (+1.66%)
NFLX   581.69 (+0.32%)
GILD   66.45 (-0.79%)
S&P 500   3,839.71 (-0.35%)
DOW   30,992.92 (-0.59%)
QQQ   325.24 (-0.34%)
AAPL   135.28 (-1.16%)
MSFT   227.32 (+1.04%)
FB   273.05 (+0.07%)
GOOGL   1,879.03 (-0.27%)
AMZN   3,285.75 (-0.64%)
TSLA   839.70 (-0.63%)
NVDA   547.12 (-1.37%)
BABA   257.09 (-1.12%)
CGC   33.32 (-0.72%)
GE   11.08 (+0.09%)
MU   84.58 (-0.51%)
AMD   95.40 (+4.23%)
NIO   58.68 (+0.58%)
T   28.65 (-0.62%)
F   11.59 (+0.52%)
ACB   10.29 (-7.88%)
BA   206.00 (-0.68%)
DIS   174.12 (+1.66%)
NFLX   581.69 (+0.32%)
GILD   66.45 (-0.79%)
Log in
NYSE:TDOC

Teladoc Health Stock Forecast, Price & News

Followed 166 Times  
$243.84
-1.66 (-0.68 %)
(As of 01/22/2021 09:34 AM ET)
Add
Compare
Today's Range
$242.06
Now: $243.84▼
$246.32
50-Day Range
$187.07
MA: $208.64▼
$246.74
52-Week Range
$93.56
Now: $243.84▼
$253.00
Volume3,789 shs
Average Volume3.32 million shs
Market Capitalization$35.35 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.3
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, expert medical services, behavioral health solutions, guidance and support, and platform and program services. The company's platform enables patients and providers to have an integrated smart user experience through mobile, Web, and phone based accessed points. 0It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. Teladoc Health, Inc. offers its products and services under the Teladoc, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. Teladoc Health, Inc. has alliance with NTT DATA Services to build nucleus for healthcare. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.
Teladoc Health logo

MarketRank™

Overall MarketRank™

1.29 out of 5 stars

Medical Sector

701st out of 1,921 stocks

Offices & Clinics Of Medical Doctors Industry

2nd out of 8 stocks

Analyst Opinion: 2.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
Current SymbolNYSE:TDOC
Previous Symbol
CUSIPN/A
CIK1477449
Webwww.teladochealth.com
Phone203-635-2002
Employees2,400

Debt

Debt-to-Equity Ratio0.43
Current Ratio6.52
Quick Ratio6.47

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$553.31 million
Price / Sales63.88
Cash FlowN/A
Price / Cash FlowN/A
Book Value$14.01 per share
Price / Book17.40

Profitability

EPS (Most Recent Fiscal Year)($1.49)
Net Income$-98,860,000.00
Net Margins-12.71%
Return on Equity-6.15%
Return on Assets-3.75%

Miscellaneous

Outstanding Shares144,961,000
Market Cap$35.35 billion
Next Earnings Date2/24/2021 (Estimated)
OptionableOptionable
$243.84
-1.66 (-0.68 %)
(As of 01/22/2021 09:34 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Teladoc Health (NYSE:TDOC) Frequently Asked Questions

How has Teladoc Health's stock been impacted by Coronavirus?

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TDOC stock has increased by 77.5% and is now trading at $243.84.
View which stocks have been most impacted by COVID-19.

Is Teladoc Health a buy right now?

29 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 12 hold ratings and 17 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Teladoc Health stock.
View analyst ratings for Teladoc Health or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Teladoc Health?

Wall Street analysts have given Teladoc Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Teladoc Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as Teladoc Health's CEO?

6,978 employees have rated Teladoc Health CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Teladoc Health's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Teladoc Health.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) issued its quarterly earnings results on Wednesday, October, 28th. The health services provider reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.33) by $0.10. The health services provider had revenue of $288.81 million for the quarter, compared to the consensus estimate of $281.54 million. Teladoc Health had a negative return on equity of 6.15% and a negative net margin of 12.71%.
View Teladoc Health's earnings history.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health issued an update on its fourth quarter 2020 After-Hours earnings guidance on Tuesday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $369-379 million, compared to the consensus revenue estimate of $347.16 million.

What price target have analysts set for TDOC?

29 equities research analysts have issued twelve-month price targets for Teladoc Health's shares. Their forecasts range from $165.00 to $305.00. On average, they expect Teladoc Health's share price to reach $236.23 in the next twelve months. This suggests that the stock has a possible downside of 3.1%.
View analysts' price targets for Teladoc Health or view Wall Street analyst' top-rated stocks.

Who are some of Teladoc Health's key competitors?

Some companies that are related to Teladoc Health include AstraZeneca (AZN), Sanofi (SNY), AstraZeneca PLC (AZN.L) (AZN), CSL (CSLLY), GlaxoSmithKline (GSK), Intuitive Surgical (ISRG), Stryker (SYK), Gilead Sciences (GILD), Anthem (ANTM), Zoetis (ZTS), Becton, Dickinson and (BDX), GlaxoSmithKline plc (GSK.L) (GSK), Vertex Pharmaceuticals (VRTX), Bayer Aktiengesellschaft (BAYRY) and Illumina (ILMN).
View all of TDOC's competitors.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), Shopify (SHOP), DocuSign (DOCU), salesforce.com (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the following people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 48, Pay $1.2M)
  • Ms. Mala Murthy, Chief Financial Officer (Age 56, Pay $647.34k)
  • Mr. David William Sides, Chief Operating Officer (Age 49, Pay $927.41k)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 45, Pay $541k)
  • Ms. Stephany Verstraete, Chief Marketing Officer & Engagement Officer (Age 51, Pay $503.37k)
  • Mr. Gabriel Raymond Cappucci CPA, CPA, Sr. VP of Fin. (Age 57, Pay $425.5k)
  • Dr. George Byron Brooks, Co-Founder
  • Mr. Patrick Thomas Feeley C.F.A., CPA, CPA, CFA, VP of Investor Relations
  • Ms. Courtney Kraemer McLeod, Director of Communication
  • Mr. Andrew Turitz, Sr. VP of Corp. Devel. (Age 47)

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Ardevora Asset Management LLP (0.17%), Peregrine Capital Management LLC (0.13%), Spence Asset Management (0.09%), Rhenman & Partners Asset Management AB (0.08%), Bainco International Investors (0.04%) and Kestra Advisory Services LLC (0.02%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David William Sides, Gabriel R Cappucci, Glen Tullman, Hemant Taneja, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete, William H Frist and Yulun Wang.
View institutional ownership trends for Teladoc Health.

Which major investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Bainco International Investors, Meridian Wealth Management LLC, Traynor Capital Management Inc., First Citizens Bank & Trust Co., Sowell Financial Services LLC, Raymond James Trust N.A., ProVise Management Group LLC, and Brookstone Capital Management. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David William Sides, Gabriel R Cappucci, Glen Tullman, Hemant Taneja, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Stephany Verstraete, William H Frist, and Yulun Wang.
View insider buying and selling activity for Teladoc Health or view top insider-selling stocks.

Which major investors are buying Teladoc Health stock?

TDOC stock was acquired by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Spence Asset Management, Rhenman & Partners Asset Management AB, Hamilton Lane Advisors LLC, Peregrine Capital Management LLC, Kestra Advisory Services LLC, DNB Asset Management AS, and Tributary Capital Management LLC.
View insider buying and selling activity for Teladoc Health or or view top insider-buying stocks.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $243.84.

How big of a company is Teladoc Health?

Teladoc Health has a market capitalization of $35.35 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladochealth.com.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.